Jefferies is bullish on 6 healthcare stocks with upside potential of up to 46%. Own any?
60-Word AI Digest
Hospital stocks extended losses amid regulatory scrutiny over cancer-drug markups and pharmacy practices. Despite the selloff, Jefferies maintained Buy ratings on six healthcare companies, citing target-price upside ranging from 22% to 46% and strong projected EBITDA growth through FY29.
Key Takeaways
- Hospital stocks extended losses amid regulatory scrutiny over cancer-drug markups and pharmacy practices.
- Despite the selloff, Jefferies maintained Buy ratings on six healthcare companies, citing target-price upside ranging from 22% to 46% and strong projected EBITDA growth through FY29.
- Full details and original dispatch available below.
Hospital stocks extended losses amid regulatory scrutiny over cancer-drug markups and pharmacy practices. Despite the selloff, Jefferies maintained Buy ratings on six healthcare companies, citing target-price upside ranging from 22% to 46% and strong projected EBITDA growth through FY29.
Original Publisher Attribution
This summary was curated from Economic Times.